Methsuximide bulk supplier for pharma manufacturers

Methsuximide 150 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150 mg

Reference Brands: Celontin (USA)

Category: Neurology

Methsuximide is a succinimide anticonvulsant that helps reduce abnormal electrical activity in the brain. It is prescribed for controlling absence seizures when other medications fail to provide adequate seizure control. The drug works by raising the seizure threshold and modulating neuronal firing. It is typically used under specialist guidance and requires monitoring due to potential side effects such as drowsiness, dizziness, and gastrointestinal discomfort.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Methsuximide — third party manufacturing & bulk supply

Methsuximide 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Methsuximide is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Methsuximide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Methsuximide →

Back to Listing

Frequently Asked Questions

Methsuximide is used for the treatment of absence (petit mal) seizures, mainly in patients who do not respond adequately to first-line anticonvulsant medications.

Methsuximide is made from the active pharmaceutical ingredient methsuximide, a succinimide derivative that works by suppressing abnormal electrical activity in the brain.

The main trade name is Celontin.

Celontin has historically been marketed by major pharmaceutical companies in the United States. Manufacturers may vary depending on the region and availability.

The generic name is methsuximide.

The brand name is Celontin.

Methsuximide is manufactured by different pharmaceutical companies in various countries depending on brand ownership and regional regulatory approvals.